Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Tempus AI, Inc. (NASDAQ:TEM) has been given a consensus recommendation of “Moderate Buy” by the ten analysts that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $48.67.

Several research analysts have recently issued reports on TEM shares. TD Cowen started coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued a “buy” rating and a $50.00 target price on the stock. Morgan Stanley started coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 target price on the stock. William Blair started coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. raised their target price on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, Piper Sandler began coverage on shares of Tempus AI in a research note on Monday, August 12th. They issued a “neutral” rating and a $40.00 target price on the stock.

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently made changes to their positions in the company. IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in shares of Tempus AI in the third quarter valued at $258,000. Renaissance Capital LLC bought a new position in Tempus AI during the third quarter worth $633,000. Exchange Traded Concepts LLC bought a new position in Tempus AI during the third quarter worth $3,458,000. Carnegie Investment Counsel bought a new position in Tempus AI during the third quarter worth $7,936,000. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in Tempus AI during the second quarter worth $5,250,000.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $49.05 on Thursday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $77.00. The stock’s 50-day moving average is $51.79. The company has a debt-to-equity ratio of 4.50, a quick ratio of 3.52 and a current ratio of 3.70.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts’ consensus estimates of ($4.41) by ($2.36). The business had revenue of $165.97 million for the quarter, compared to analysts’ expectations of $159.10 million. On average, sell-side analysts expect that Tempus AI will post -6.51 EPS for the current fiscal year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.